Literature DB >> 19625690

Long-term hypoxia enhances ACTH response to arginine vasopressin but not corticotropin-releasing hormone in the near-term ovine fetus.

Charles A Ducsay1, Malgorzata Mlynarczyk, Kanchan M Kaushal, Kim Hyatt, Krista Hanson, Dean A Myers.   

Abstract

This study tested the hypothesis that long-term hypoxia (LTH) results in enhanced fetal corticotrope sensitivity to the ACTH secretagogues, corticotropin-releasing hormone (CRH), and AVP. Ewes were maintained at high altitude (3,820 m) from 40 to 130-131 days of gestation. Upon return to the laboratory, hypoxia was maintained by maternal nitrogen infusion. Vascular catheters were placed in both LTH (n = 4) and normoxic controls (n = 4). Each fetus received a 15-min infusion of either saline, 100 ng/kg of ovine CRH, or 20 ng/kg of AVP/min over 3 consecutive days in a randomized order. Fetal blood samples were collected at 0, 15, 30, 60, and 90 min after the start of infusion and analyzed for ACTH(1-39), ACTH precursors, and cortisol. Anterior pituitaries were collected from additional noninstrumented fetuses for analysis of vasopressin receptor 1b (V1b) mRNA and protein. Basal plasma concentrations of both ACTH(1-39) and ACTH precursors were higher in LTH fetuses and were not altered by saline infusion. In response to CRH, ACTH(1-39) increased in both groups and was higher in the LTH group compared with control (P < 0.05). When analyzed as sum of ACTH(1-39) released (Delta0-90 min) above basal, CRH released equal amounts of ACTH(1-39) in both groups. In LTH fetuses, AVP evoked a greater ACTH(1-39) release (P < 0.05) when analyzed as an increased sum of ACTH(1-39) (Delta0-90 min) above basal. Both CRH and AVP elicited a release of ACTH precursors with no differences observed between LTH and control. AVP and CRH elicited significant increases in cortisol, which were higher in response to AVP than CRH. V1b mRNA and protein were elevated in the anterior pituitary of LTH fetuses compared with control. LTH significantly increases pituitary sensitivity to AVP. This enhanced sensitivity may be a mechanism of our previously observed enhanced corticotrope function.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19625690      PMCID: PMC2739789          DOI: 10.1152/ajpregu.00220.2009

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  24 in total

1.  Long-term hypoxia alters ovine fetal endocrine and physiological responses to hypotension.

Authors:  Keiichi Adachi; Hikaru Umezaki; Kanchan M Kaushal; Charles A Ducsay
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2004-03-11       Impact factor: 3.619

2.  Long-term hypoxia enhances proopiomelanocortin processing in the near-term ovine fetus.

Authors:  Dean A Myers; Paige A Bell; Kimberly Hyatt; Malgorzata Mlynarczyk; Charles A Ducsay
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2004-12-23       Impact factor: 3.619

3.  A specific carrier substance for human corticotrophin releasing factor in late gestational maternal plasma which could mask the ACTH-releasing activity.

Authors:  E A Linton; C D Wolfe; D P Behan; P J Lowry
Journal:  Clin Endocrinol (Oxf)       Date:  1988-03       Impact factor: 3.478

4.  Effect of bilateral splanchnic nerve section on adrenal function in the ovine fetus.

Authors:  D A Myers; D Robertshaw; P W Nathanielsz
Journal:  Endocrinology       Date:  1990-11       Impact factor: 4.736

5.  Long-term hypoxia increases leptin receptors and plasma leptin concentrations in the late-gestation ovine fetus.

Authors:  Charles A Ducsay; Kim Hyatt; Malgorzata Mlynarczyk; Kanchan M Kaushal; Dean A Myers
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-07-06       Impact factor: 3.619

6.  Time-trend analysis of plasma cortisol concentrations in the fetal sheep in relation to parturition.

Authors:  D M Magyar; D Fridshal; C W Elsner; T Glatz; J Eliot; A H Klein; K C Lowe; J E Buster; P W Nathanielsz
Journal:  Endocrinology       Date:  1980-07       Impact factor: 4.736

Review 7.  The fetal placental hypothalamic-pituitary-adrenal (HPA) axis, parturition and post natal health.

Authors:  J R Challis; D Sloboda; S G Matthews; A Holloway; N Alfaidy; F A Patel; W Whittle; M Fraser; T J Moss; J Newnham
Journal:  Mol Cell Endocrinol       Date:  2001-12-20       Impact factor: 4.102

8.  Does reduction of circulating prostaglandin E2 reduce fetal hypothalamic-pituitary-adrenal axis activity?

Authors:  Sharon K Reimsnider; Charles E Wood
Journal:  J Soc Gynecol Investig       Date:  2005-05

9.  The biosynthesis and secretion of adrenocorticotropin by the ovine anterior pituitary is predominantly regulated by arginine vasopressin (AVP). Evidence that protein kinase C mediates the action of AVP.

Authors:  J P Liu; P J Robinson; J W Funder; D Engler
Journal:  J Biol Chem       Date:  1990-08-25       Impact factor: 5.157

10.  Long-term hypoxia alters endocrine and physiologic responses to umbilical cord occlusion in the ovine fetus.

Authors:  Toshiko Imamura; Hikaru Umezaki; Kanchan M Kaushal; Charles A Ducsay
Journal:  J Soc Gynecol Investig       Date:  2004-04
View more
  10 in total

Review 1.  Epigenetic mechanisms in developmental programming of adult disease.

Authors:  Man Chen; Lubo Zhang
Journal:  Drug Discov Today       Date:  2011-09-16       Impact factor: 7.851

2.  Long-term hypoxia enhances cortisol biosynthesis in near-term ovine fetal adrenal cortical cells.

Authors:  Vladimir E Vargas; Kanchan M Kaushal; Tshepo Monau; Dean A Myers; Charles A Ducsay
Journal:  Reprod Sci       Date:  2010-11-15       Impact factor: 3.060

3.  Hypoxia Inducible Factor Expression and Angiogenesis - Analysis in the Pituitary Gland and Patterns of Death.

Authors:  Maria Kouroupi; Efthimios Sivridis; Dimitrios Papazoglou; Michael I Koukourakis; Alexandra Giatromanolaki
Journal:  In Vivo       Date:  2018 Jan-Feb       Impact factor: 2.155

4.  Expression of StAR and Key Genes Regulating Cortisol Biosynthesis in Near Term Ovine Fetal Adrenocortical Cells: Effects of Long-Term Hypoxia.

Authors:  Vladimir E Vargas; Dean A Myers; Kanchan M Kaushal; Charles A Ducsay
Journal:  Reprod Sci       Date:  2017-05-03       Impact factor: 3.060

5.  Adrenocorticotropic Hormone and PI3K/Akt Inhibition Reduce eNOS Phosphorylation and Increase Cortisol Biosynthesis in Long-Term Hypoxic Ovine Fetal Adrenal Cortical Cells.

Authors:  Elizabeth A Newby; Kanchan M Kaushal; Dean A Myers; Charles A Ducsay
Journal:  Reprod Sci       Date:  2015-02-05       Impact factor: 3.060

6.  Nitric oxide inhibits ACTH-induced cortisol production in near-term, long-term hypoxic ovine fetal adrenocortical cells.

Authors:  Tshepo R Monau; Vladimir E Vargas; Lubo Zhang; Dean A Myers; Charles A Ducsay
Journal:  Reprod Sci       Date:  2010-08-16       Impact factor: 3.060

7.  Extracellular signal-regulated kinases (ERK1/2) signaling pathway plays a role in cortisol secretion in the long-term hypoxic ovine fetal adrenal near term.

Authors:  Vladimir E Vargas; Kanchan M Kaushal; Tshepo R Monau; Dean A Myers; Charles A Ducsay
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-02-20       Impact factor: 3.619

8.  Leptin receptor antagonist treatment ameliorates the effects of long-term maternal hypoxia on adrenal expression of key steroidogenic genes in the ovine fetus.

Authors:  Charles A Ducsay; Ken Furuta; Vladimir E Vargas; Kanchan M Kaushal; Krista Singleton; Kimberly Hyatt; Dean A Myers
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-01-23       Impact factor: 3.619

Review 9.  Adrenocortical and adipose responses to high-altitude-induced, long-term hypoxia in the ovine fetus.

Authors:  Dean A Myers; Charles A Ducsay
Journal:  J Pregnancy       Date:  2012-05-14

10.  Gestational hypoxia modulates expression of corticotropin-releasing hormone and arginine vasopressin in the paraventricular nucleus in the ovine fetus.

Authors:  Dean A Myers; Krista Singleton; Christy Kenkel; Kanchan M Kaushal; Charles A Ducsay
Journal:  Physiol Rep       Date:  2016-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.